AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10352774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy at 10 degrees C (N = 7)
Number of subjects: 21
Study 10352774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy at 5 degrees C (N = 7)
Number of subjects: 21
Study 10352774 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 7)
Number of subjects: 21
Study 7860766 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (normofiltration)
Number of subjects: 23
Study 7860766 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (hypofiltration)
Number of subjects: 23
Study 2016397 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing teddy bear
Number of subjects: 45
Study 2016397 — intervention group
Group type: COMPARATOR
Intervention: Nonbreathing bear
Number of subjects: 45
Study 7129723 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% preliminary tension
Number of subjects: 13
Study 7129723 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% preliminary tension
Number of subjects: 13
Study 7129723 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% preliminary tension
Number of subjects: 13
Study 7129723 — intervention group
Group type: EXPERIMENTAL
Intervention: 0% to 70% of maximal voluntary contraction value (MVC)
Number of subjects: 13
Study 7129723 — intervention group
Group type: EXPERIMENTAL
Intervention: RFD
Number of subjects: 13
Study 31987228 — intervention group
Group type: EXPERIMENTAL
Intervention: S. officinalis extract (330 mg daily for 8 weeks)
Number of subjects: 60
Study 29485356 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week corrective exercise program
Number of subjects: 26
Study 29485356 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 26
Study 28544610 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol-enriched virgin olive oils (FVOO) and control virgin olive oil (VOO)
Number of subjects: 0
Study 28544610 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol-enriched virgin olive oil with thyme (FVOOT)
Number of subjects: 0
Study 28544610 — intervention group
Group type: COMPARATOR
Intervention: Control virgin olive oil (VOO)
Number of subjects: 0
Study 24674154 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized coaching
Number of subjects: 230
Study 24674154 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study 24177170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting (SA) with DMG LUXACORE Smartmix Dual
Number of subjects: 80
Study 24177170 — intervention group
Group type: EXPERIMENTAL
Intervention: Silanization (SI) with DMG LUXACORE Smartmix Dual
Number of subjects: 80
Study 24177170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting followed by silanization (SS) with DMG LUXACORE Smartmix Dual
Number of subjects: 80
Study 24177170 — intervention group
Group type: COMPARATOR
Intervention: No pre‐treatment (NS, control) with DMG LUXACORE Smartmix Dual
Number of subjects: 80
Study 24177170 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 80
Study 24177170 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F2.0
Number of subjects: 80
Study 23041682 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural block
Number of subjects: 60
Study 23041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block
Number of subjects: 60
Study 23041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study 19352324 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF gene therapy (2,000 microg of VEGF plasmid DNA)
Number of subjects: 93
Study 19352324 — intervention group
Group type: COMPARATOR
Intervention: Placebo (buffered saline)
Number of subjects: 93
Study 19352324 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF gene therapy
Number of subjects: 93
Study 19352324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 17445644 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic low-molecular-weight heparin for 1 week (Group 2)
Number of subjects: 75
Study 17445644 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional heparin for 1 week (Group 3)
Number of subjects: 75
Study 17445644 — intervention group
Group type: COMPARATOR
Intervention: No heparinization (Group 1)
Number of subjects: 75
Study 17445644 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional heparin (Group 3)
Number of subjects: 75
Study 15878544 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 108
Study 15878544 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) followed by acenocoumarol
Number of subjects: 108
Study 15878544 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-analysis
Number of subjects: 108
Study 12659411 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated breast-feeding counselling (once before delivery and at 1, 2, 3, 4, 5, 6, 9, and 12 months)
Number of subjects: 174
Study 12659411 — intervention group
Group type: COMPARATOR
Intervention: Single session of breast-feeding counselling (just before delivery)
Number of subjects: 174
Study 12659411 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated breast-feeding counselling
Number of subjects: 174
Study 12659411 — intervention group
Group type: COMPARATOR
Intervention: Single session of breast-feeding counselling
Number of subjects: 174
Study 9438781 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 8
Study 9438781 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine infusion
Number of subjects: 8
Study 9676668 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked review (one reviewer received a manuscript with author identity masked)
Number of subjects: 118
Study 9676668 — intervention group
Group type: COMPARATOR
Intervention: Unmasked review (one reviewer received an unmasked manuscript)
Number of subjects: 118
Study 9676668 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall masking success
Number of subjects: 118
Study 9676668 — intervention group
Group type: EXPERIMENTAL
Intervention: Manuscripts by well-known authors
Number of subjects: 118
Study 9676668 — intervention group
Group type: EXPERIMENTAL
Intervention: Successfully masked manuscripts
Number of subjects: 118
Study 1929613 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiation by the brachytherapy technique
Number of subjects: 1600
Study 1929613 — intervention group
Group type: COMPARATOR
Intervention: Eligible patients not randomized to the trial
Number of subjects: 1600
Study 6214228 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin plus amikacin
Number of subjects: 297
Study 6214228 — intervention group
Group type: COMPARATOR
Intervention: Carbenicillin plus amikacin
Number of subjects: 297
Study 30667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Active microcurrent emitter
Number of subjects: 71
Study 30667597 — intervention group
Group type: COMPARATOR
Intervention: Sham device (placebo)
Number of subjects: 71
Study 28119041 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus oxaliplatin (XELOX)
Number of subjects: 50
Study 28119041 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine monotherapy (X)
Number of subjects: 50
Study 26648706 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/formoterol (two doses)
Number of subjects: 0
Study 23289773 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) including psychological preparation activities and psychologist's support during all phases of the operatory iter.
Number of subjects: 50
Study 23289773 — intervention group
Group type: COMPARATOR
Intervention: Distraction activities (group 2) as a control intervention.
Number of subjects: 50
Study 23289773 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) for mothers' anxiety.
Number of subjects: 50
Study 23289773 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) for mothers' satisfaction.
Number of subjects: 50
Study 21621929 — intervention group
Group type: EXPERIMENTAL
Intervention: IBT plus acamprosate
Number of subjects: 371
Study 21621929 — intervention group
Group type: COMPARATOR
Intervention: IBT plus placebo
Number of subjects: 371
Study 21621929 — intervention group
Group type: COMPARATOR
Intervention: TAU plus acamprosate
Number of subjects: 371
Study 17530622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy intervention
Number of subjects: 238
Study 17530622 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 238
Study 16423848 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus carboplatin (IP)
Number of subjects: 70
Study 16423848 — intervention group
Group type: COMPARATOR
Intervention: Etoposide plus carboplatin (EP)
Number of subjects: 70
Study 12614418 — intervention group
Group type: EXPERIMENTAL
Intervention: Three treatments with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144
Study 12614418 — intervention group
Group type: EXPERIMENTAL
Intervention: Two treatments with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144
Study 12614418 — intervention group
Group type: EXPERIMENTAL
Intervention: Single treatment with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144
Study 10840428 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative enema
Number of subjects: 50
Study 10840428 — intervention group
Group type: COMPARATOR
Intervention: No enema
Number of subjects: 50
Study 8638803 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (< or = 2.4% inspired concentration)
Number of subjects: 50
Study 8638803 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (< or = 1.9% inspired concentration)
Number of subjects: 50
Study 8638803 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50
Study 1998281 — intervention group
Group type: EXPERIMENTAL
Intervention: Questran Light (4 g of cholestyramine in 5 g of powder per pack)
Number of subjects: 61
Study 1998281 — intervention group
Group type: COMPARATOR
Intervention: Questran (4 g of cholestyramine in 9 g of powder per pack)
Number of subjects: 61
Study 1998281 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Questran Light and Questran
Number of subjects: 61
Study 6826532 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 60
Study 6826532 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 60
Study 6826532 — intervention group
Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 60
Study 31075171 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate therapy
Number of subjects: 0
Study 31075171 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG3, C1q fixation, and opsonic phagocytosis seropositivity
Number of subjects: 0
Study 29609158 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower extremity power training
Number of subjects: 22
Study 29609158 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 27014821 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate + ulinastatin
Number of subjects: 67
Study 27014821 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 67
Study 24254301 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional beverage (FB) consumed 187 mL acutely and twice a day for 15 days chronically
Number of subjects: 26
Study 24254301 — intervention group
Group type: COMPARATOR
Intervention: Control placebo beverage
Number of subjects: 26
Study 22414847 — intervention group
Group type: EXPERIMENTAL
Intervention: Atmospheric pressure nonequilibrium plasmas (APNPs) for 5 minutes
Number of subjects: 0
Study 22414847 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX) for 5 minutes
Number of subjects: 0
Study 22414847 — intervention group
Group type: EXPERIMENTAL
Intervention: Atmospheric pressure nonequilibrium plasmas (APNPs) for 5, 10, and 15 minutes
Number of subjects: 0
Study 22414847 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX) for 5, 10, and 15 minutes
Number of subjects: 0
Study 20852059 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing with peri-infarct LV lead placement (cardiac resynchronization therapy [CRT]-D)
Number of subjects: 80
Study 20852059 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 80
Study 17412965 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual implicit memory measured through subjective ratings of squiggle meaningfulness and behavioral indications of memory.
Number of subjects: 0
Study 17412965 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit memory measured through contrasts based on meaningfulness ratings and memory judgments.
Number of subjects: 0
Study 16354848 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 1218
Study 16354848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior rehabilitation status
Number of subjects: 1218
Study 12221737 — intervention group
Group type: EXPERIMENTAL
Intervention: RDC/TMD depression scale
Number of subjects: 0
Study 12221737 — intervention group
Group type: EXPERIMENTAL
Intervention: RDC/TMD non-specific physical symptoms scale
Number of subjects: 0
Study 12221737 — intervention group
Group type: EXPERIMENTAL
Intervention: RDC/TMD graded chronic pain scale
Number of subjects: 0
Study 9736437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 380
Study 9736437 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 380
Study 9736437 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting nisoldipine
Number of subjects: 380
Study 9736437 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 380
Study 9736437 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 380
Study 9736437 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 380
Study 9125457 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear acceleration steps of 0.05 g, 0.1 g, or 0.24 g amplitude
Number of subjects: 6
Study 9125457 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing earth‐fixed targets at 30 cm, 60 cm, or 280 cm
Number of subjects: 6
Study 2576366 — intervention group
Group type: EXPERIMENTAL
Intervention: Picumast dihydrochloride (2 mg twice daily orally)
Number of subjects: 400
Study 2576366 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen (1 mg twice daily orally)
Number of subjects: 400
Study 2576366 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 400
Study 963397 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 24
Study 28464241 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS Preschool Program
Number of subjects: 285
Study 28692017 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to physical activity (BPA)
Number of subjects: 0
Study 28692017 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to healthy eating (BHE)
Number of subjects: 0
Study 28692017 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BHE
Number of subjects: 0
Study 26627982 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (IV or PO administration totaling more than 20 mg methylprednisolone equivalents during one calendar day)
Number of subjects: 745
Study 26627982 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids use in non-survivor group
Number of subjects: 745
Study 23417481 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg)
Number of subjects: 16
Study 23417481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 21753729 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 99
Study 21753729 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary Pain Intervention (MPI) program
Number of subjects: 99
Study 19112077 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Parent Involvement (CPI) scores at or above the median among primary caregivers
Number of subjects: 309
Study 19112077 — intervention group
Group type: COMPARATOR
Intervention: Collaborative Parent Involvement (CPI) scores below the median for both caregivers
Number of subjects: 309
Study 19112077 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Parent Involvement (CPI) scores of primary caregivers
Number of subjects: 309
Study 16945121 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg twice daily
Number of subjects: 457
Study 16945121 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg once daily
Number of subjects: 457
Study 16945121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 16945121 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg twice daily (severe symptoms subgroup)
Number of subjects: 457
Study 15646158 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians who had heard about EBM
Number of subjects: 409
Study 15646158 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical appraisal knowledge and EBM knowledge scores
Number of subjects: 409
Study 11564369 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoablation followed by stem cell rescue
Number of subjects: 0
Study 11564369 — intervention group
Group type: EXPERIMENTAL
Intervention: Microchimerism
Number of subjects: 0
Study 8995085 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ERCP and papillotomy
Number of subjects: 238
Study 8995085 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 238
Study 8422204 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised resistance exercise training for 5 months
Number of subjects: 46
Study 8422204 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 3321877 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% and 2% pilocarpine
Number of subjects: 93
Study 3321877 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% and 4% pilocarpine
Number of subjects: 93
Study 3321877 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 93
Study 28463013 — intervention group
Group type: EXPERIMENTAL
Intervention: Community members' ratings of voice quality using Voice Quality/Acceptability questionnaire
Number of subjects: 66
Study 28463013 — intervention group
Group type: EXPERIMENTAL
Intervention: Community members' ratings of voice quality using Communicative Suitability Scale
Number of subjects: 66
Study 28463013 — intervention group
Group type: EXPERIMENTAL
Intervention: Community members' gender perception question
Number of subjects: 66
Study 28463013 — intervention group
Group type: COMPARATOR
Intervention: Clinicians' ratings of voice quality
Number of subjects: 66
Study 28463013 — intervention group
Group type: COMPARATOR
Intervention: Patients' self-rated voice quality and acceptability
Number of subjects: 66
Study 28463013 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice acceptability ratings by community members
Number of subjects: 66
Study 27166233 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem CR 12.5 mg
Number of subjects: 15
Study 27166233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 24766549 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 22100963 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) for 12 weeks
Number of subjects: 100
Study 22100963 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 100
Study 20431394 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir/Lamivudine
Number of subjects: 385
Study 20431394 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir/Emtricitabine
Number of subjects: 385
Study 20431394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 385
Study 18566972 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. placebo administration with glucose expectation
Number of subjects: 24
Study 15772863 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-mg caffeine and 250-mg theobromine
Number of subjects: 64
Study 15772863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 11949898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Field Theory (DFT) predictions
Number of subjects: 0
Study 11949898 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving to an 'A' location on successive trials
Number of subjects: 0
Study 11949898 — intervention group
Group type: EXPERIMENTAL
Intervention: First trial to a nearby 'B' location
Number of subjects: 0
Study 11949898 — intervention group
Group type: EXPERIMENTAL
Intervention: Category Adjustment (CA) model
Number of subjects: 0
Study 10070918 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bag disconnect system (B)
Number of subjects: 120
Study 10070918 — intervention group
Group type: COMPARATOR
Intervention: Y-set disconnect system (Y)
Number of subjects: 120
Study 7478687 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile Water Injections (SWI)
Number of subjects: 117
Study 7478687 — intervention group
Group type: COMPARATOR
Intervention: Saline Injections (PSI)
Number of subjects: 117
Study 2205255 — intervention group
Group type: EXPERIMENTAL
Intervention: Care from nurse practitioners
Number of subjects: 0
Study 2205255 — intervention group
Group type: COMPARATOR
Intervention: Conventional care from family physicians
Number of subjects: 0
Study 359067 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine + DTIC + duborimycin
Number of subjects: 0
Study 359067 — intervention group
Group type: COMPARATOR
Intervention: Vincristine + DTIC
Number of subjects: 0
Study 31181657 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 100
Study 31181657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 28389217 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of octopamine
Number of subjects: 10
Study 28389217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 25731939 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants born preterm
Number of subjects: 0